qSOFA in General Wards: the Accuracy in Diagnosis of Sepsis
NCT ID: NCT02930070
Last Updated: 2016-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2016-09-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of qSOFA in the Latin America Sepsis Institute Database
NCT03158493
A Prospective Observational Study of Sepsis
NCT05309889
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
qSOFA(+)SOFA(+)
Infection patients who has a qSOFA\>=2 and SOFA\>=2 in a same day within 28 day of hospital stay.This group has the greatest priority in the competition of inclusion of groups.
No interventions assigned to this group
qSOFA(-)SOFA(+)
Infection patients who has a qSOFA\<2 and SOFA\>=2 in a same day within 28 day of hospital stay.This group has the secondary priority in the competition of inclusion of groups.
No interventions assigned to this group
qSOFA(+)SOFA(-)
Infection patients who has a qSOFA\>=2 and SOFA\<2 in a same day within 28 day of hospital stay.This group has the third priority in the competition of inclusion of groups.
No interventions assigned to this group
qSOFA(-)SOFA(-)
Infection patients who has a qSOFA\<2 and SOFA\<2 in a same day within 28 day of hospital stay.This group has the least priority in the competition of inclusion of groups.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Weng, MD
Role: PRINCIPAL_INVESTIGATOR
Medical ICU, Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical ICU,Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M; Sepsis Definitions Task Force. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):775-87. doi: 10.1001/jama.2016.0289.
Churpek MM, Zadravecz FJ, Winslow C, Howell MD, Edelson DP. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients. Am J Respir Crit Care Med. 2015 Oct 15;192(8):958-64. doi: 10.1164/rccm.201502-0275OC.
Luo J, Jiang W, Weng L, Peng J, Hu X, Wang C, Liu G, Huang H, Du B. Usefulness of qSOFA and SIRS scores for detection of incipient sepsis in general ward patients: A prospective cohort study. J Crit Care. 2019 Jun;51:13-18. doi: 10.1016/j.jcrc.2019.01.012. Epub 2019 Jan 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
qSOFA GAUGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.